pd 98059 has been researched along with octaarginine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiba, N; Futaki, S; Imanishi, M; Kumaki, S; Looi, CY; Sasahara, Y; Sato, M; Takaki, S; Tsuchiya, S | 1 |
1 other study(ies) available for pd 98059 and octaarginine
Article | Year |
---|---|
Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; COS Cells; Enzyme Activation; Flavonoids; Gene Transfer Techniques; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Leukemia, Megakaryoblastic, Acute; Mitogen-Activated Protein Kinases; Mutant Proteins; Oligopeptides; Protein Binding; Proteins; Pyrrolidines; Recombinant Fusion Proteins; STAT Transcription Factors; Sulfonamides; Thrombopoietin | 2011 |